Harnessing data science to advance radiation oncology
Open Access
- 1 July 2020
- journal article
- review article
- Published by Wiley in Molecular Oncology
- Vol. 14 (7), 1514-1528
- https://doi.org/10.1002/1878-0261.12685
Abstract
Radiation oncology, a major treatment modality in the care of patients with malignant disease, is a technology- and computer-intensive medical specialty. As such, it should lend itself ideally to data science methods, where computer science, statistics, and clinical knowledge are combined to advance state-of-the-art care. Nevertheless, data science methods in radiation oncology research are still in their infancy and successful applications leading to improved patient care remain scarce. Here, we discuss data interoperability issues within and across organizational boundaries that hamper the introduction of big data and data science techniques in radiation oncology. At the semantic level, creating common underlying models and codification of the data, including the use of data elements with standardized definitions, an ontology, remains a work in progress. Methodological issues in data science and in the use of large population-based health data registries are identified. We show that data science methods and big data cannot replace randomized clinical trials in comparative effectiveness research by reviewing a series of instances where the outcomes of big data analyses and randomized trials are at odds. We also discuss the modern wave of machine learning and artificial intelligence as represented by deep learning and convolutional neural networks. Finally, we identify promising research avenues and remain optimistic that the data sources in radiation oncology can be linked to yield important insights in the near future. We argue that data science will be a valuable complement to, but not a replacement of, the traditional hypothesis-driven translational research chain and the randomized clinical trials that form the backbone of evidence-based medicine.Funding Information
- Maryland Department of Health and Mental Hygiene
- Varian Medical Systems
- National Cancer Institute (P30 CA 134274‐04)
- Kræftens Bekæmpelse (R231‐A13976)
This publication has 72 references indexed in Scilit:
- Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factorsActa Oncologica, 2013
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI Journal of the National Cancer Institute, 2013
- A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitisActa Oncologica, 2012
- Raise standards for preclinical cancer researchNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Radiation Dose–Volume Effects in the LungInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Causal inference in statistics: An overviewStatistics Surveys, 2009
- Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathologyNature Reviews Cancer, 2006
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003